Shares of Rite Aid RAD fell 0.4% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share decreased 110.81% year over year to ($0.78), which missed the estimate of ($0.76).
Revenue of $5,917,000,000 higher by 3.32% year over year, which beat the estimate of $5,800,000,000.
Outlook
Rite Aid said it sees Q1 sales of $6.1 billiob to $6.3 billion.
Conference Call Details
Date: Apr 15, 2021
Time: 08:30 AM
ET Webcast URL: https://www.riteaid.com/corporate/investor-relations/presentations
Recent Stock Performance
52-week high: $32.48
52-week low: $8.86
Price action over last quarter: Up 1.77%
Company Overview
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal-care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.